Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Receivables (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Receivables for 17 consecutive years, with $777.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 38.85% year-over-year to $777.8 million, compared with a TTM value of $777.8 million through Dec 2025, up 38.85%, and an annual FY2025 reading of $700.0 million, down 1.46% over the prior year.
  • Receivables was $777.8 million for Q4 2025 at Dolby Laboratories, up from $700.0 million in the prior quarter.
  • Across five years, Receivables topped out at $781.4 million in Q1 2025 and bottomed at $330.1 million in Q3 2021.
  • Average Receivables over 5 years is $555.2 million, with a median of $541.9 million recorded in 2023.
  • The sharpest move saw Receivables tumbled 35.87% in 2022, then soared 68.52% in 2023.
  • Year by year, Receivables stood at $468.3 million in 2021, then soared by 56.49% to $732.8 million in 2022, then rose by 0.43% to $735.9 million in 2023, then dropped by 23.87% to $560.2 million in 2024, then skyrocketed by 38.85% to $777.8 million in 2025.
  • Business Quant data shows Receivables for DLB at $777.8 million in Q4 2025, $700.0 million in Q3 2025, and $502.0 million in Q2 2025.